Bank of America upgrades St James's Place to 'Buy' after share plunge

Attractive entry point for 'quality' franchise

Valeria Martinez
clock • 2 min read

The Bank of America has upgraded St James’s Place to ‘Buy’ from ‘Neutral’ in light of the recent share price decline, which it believes undervalues a “quality" and "market-leading” franchise.

The advice giant's shares have fallen by over 26% since the release of its results for the first half of 2023, according to Morningstar data. The H1 2023 results laid out plans to cap product charges at 85 basis points a year for clients who have been invested for a decade. In a research note on Friday (4 August), Bank of America analysts Andrew Sinclair, David Barma and Freya Kong said this came as a shock to investors, compounding an already challenging backdrop for flows as the cost-of-living crisis bites UK retail savers.  However, they said that although the backdrop will remain ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Companies

Monzo fined £21m by FCA for failings in financial crime controls

Monzo fined £21m by FCA for failings in financial crime controls

Around 34,000 high-risk clients onboarded

Linus Uhlig
clock 08 July 2025 • 2 min read
Citi becomes minority investor in HANetf

Citi becomes minority investor in HANetf

Growing interest in European ETFs

Patrick Brusnahan
clock 03 July 2025 • 2 min read
AstraZeneca CEO mulls moving listing to the US – reports

AstraZeneca CEO mulls moving listing to the US – reports

Latest blow to LSE

Linus Uhlig
clock 02 July 2025 • 1 min read
Trustpilot